Daniel H. Wiseman

ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia

Tamara Maes, Cristina Mascaró, Iñigo Tirapu et al. · Cancer Cell · 2018 · 337 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis

Akihide Yoshimi, Kuan‐Ting Lin, Daniel H. Wiseman et al. · Nature · 2019 · 226 citations

Life Sciences, Genetics, Molecular Biology +14

Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia

Alba Maiqués-Díaz, Gary J. Spencer, James T. Lynch et al. · Cell Reports · 2018 · 222 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD)

Pranesh Chakraborty, Klaus Schmitz‐Abe, Erin K. Kennedy et al. · Blood · 2014 · 180 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD)

Daniel H. Wiseman, Alison May, Stephen Jolles et al. · Blood · 2013 · 115 citations · Full text

Medicine, Hematology, Pediatrics +17